The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT04163835
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 150 participants
- Registry
-
NCT04163835
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04163835. Randomized; double masking; primary purpose treatment. Start 2015-09-01 (actual); primary completion 2022-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats
- Condition
- Atrial Premature Complexes
- Intervention (Drug)
- Normal-dose Wenxin Granules
- Intervention (Drug)
- 1/2 Normal-dose Wenxin Granules
- Intervention (Drug)
- Twice Normal-dose Wenxin Granules
- Intervention (Drug)
- Placebo
- Lead sponsor
- China Academy of Chinese Medical Sciences
Record details
- Record id
cardio:ct-nct04163835- Content hash
a1b3a7d0c98e03e2d0f13ee4d130e0c6a7de4ebf3dcb399633413915d2b7a300